相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer
A. C. Tree et al.
CLINICAL ONCOLOGY (2020)
Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study
A. Sujenthiran et al.
CLINICAL ONCOLOGY (2020)
ECCO Essential Requirements for Quality Cancer Care: Prostate cancer
Maurizio Brausi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Ultrahypofractionated versus hypofractionated and conventionally fractionated radiation therapy for localized prostate cancer: A systematic review and meta-analysis of phase III randomized trials
Eric J. Lehrer et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer
Leif-Erik D. Schumacher et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR-Linac
D. M. de Muinck Keizer et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care: The Case of Prostate Cancer
Charisma Hehakaya et al.
FRONTIERS IN ONCOLOGY (2020)
MR-Guided Radiotherapy for Prostate Cancer
Boris R. Tocco et al.
FRONTIERS IN ONCOLOGY (2020)
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies
William C. Jackson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial
Vidit Sharma et al.
JOURNAL OF UROLOGY (2019)
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results
Anna M. E. Bruynzeel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
The transformation of radiation oncology using real-time magnetic resonance guidance: A review
William A. Hall et al.
EUROPEAN JOURNAL OF CANCER (2019)
Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients
David M. Routman et al.
BRACHYTHERAPY (2019)
Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling
Janneke P. C. Grutters et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2019)
Prostate cancer - Advantages and disadvantages of MR-guided RT
Julia Murray et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Adaptive radiotherapy: The Elekta Unity MR-linac concept
Dennis Winkel et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Prospective four years of evaluation of erectile function after low-dose-rate prostate brachytherapy using baseline IIEF-5 > 16
Nadja Schoentgen et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2019)
Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A Game Changer for Prostate Treatment?
Angela U. Pathmanathan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Discounting in Economic Evaluations
Arthur E. Attema et al.
PHARMACOECONOMICS (2018)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years
Daniel A. Barocas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Fast online replanning for interfraction rotation correction in prostate radiotherapy
Charis Kontaxis et al.
MEDICAL PHYSICS (2017)
Cost evaluation to optimise radiation therapy implementation in different income settings: A time-driven. activity-based analysis
Jacob Van Dyk et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility Analysis
J. Helou et al.
CLINICAL ONCOLOGY (2017)
The development of the MRI linac system for online MRI-guided radiotherapy: a clinical update
J. J. W. Lagendijk et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Efficacy and Safety of Sildenafil by Age in Men With Erectile Dysfunction
Irwin Goldstein et al.
JOURNAL OF SEXUAL MEDICINE (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F. C. Hamdy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?
Ben G. L. Vanneste et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Comparative cost-effectiveness of focal and total salvage 125I brachytherapy for recurrent prostate cancer after primary radiotherapy
Max Peters et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2016)
The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development
Linda G. W. Kerkmeijer et al.
FRONTIERS IN ONCOLOGY (2016)
Epidemiology of Prostate Cancer
Muhammad Naeem Bashir
Asian Pacific Journal of Cancer Prevention (2015)
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
Melina Arnold et al.
EUROPEAN JOURNAL OF CANCER (2015)
Better Toxicity Outcomes With HDR and LDR Brachytherapy in Comparison With External Beam Radiation Therapy for Prostate Cancer
T. Lim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
A new methodology for inter- and intrafraction plan adaptation for the MR-linac
C. Kontaxis et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?
Ben G. L. Vanneste et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Cost of prostate image-guided radiation therapy: Results of a randomized trial
Lionel Perrier et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Fast online Monte Carlo-based IMRT planning for the MRI linear accelerator
G. H. Bol et al.
PHYSICS IN MEDICINE AND BIOLOGY (2012)
Early Assessment of Medical Technologies to Inform Product Development and Market Access A Review of Methods and Applications
Maarten IJzerman et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2011)
How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons
Andrea Peeters et al.
RADIOTHERAPY AND ONCOLOGY (2010)
PREDICTIVE FACTORS FOR ACUTE AND LATE URINARY TOXICITY AFTER PERMANENT PROSTATE BRACHYTHERAPY: LONG-TERM OUTCOME IN 712 CONSECUTIVE PATIENTS
Mira Keyes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Integrating a 1.5 T MRI scanner with a 6 MV accelerator: proof of concept
B. W. Raaymakers et al.
PHYSICS IN MEDICINE AND BIOLOGY (2009)
The NICE cost-effectiveness threshold - What it is and what that means
Christopher McCabe et al.
PHARMACOECONOMICS (2008)
High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients
Irene M. Lips et al.
RADIATION ONCOLOGY (2008)
Implications of learning effects for hospital costs of new health technologies:: The case of intensity modulated radiation therapy
Julia Bonastre et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2007)
分享论文
